NLRP3 and non-small cell lung carcinoma: We confirmed that knockdown of LINC00969 prevented EZH2 binding to the NLRP3 promoter and inhibited H3K27 trimethylation, in turn inhibiting the NLRP3-mediated pyroptosis pathway, thus contributing to gefitinib resistance in NSCLC.